Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Reich Kristian | Chief Scientific Officer | 48 | $0 | $19.56M | 2026-07-27 |
| Santos da Silva Jorge | Chief Executive Officer | 25 | $0 | $19.15M | 2026-07-10 |
| Bodenstedt Matthias | Chief Financial Officer | 24 | $98.8K | $9.12M | 2026-06-22 |
| Phillips Andrew John | Director | 5 | $0 | $0 | 2026-06-17 |
| Xavier Ramnik | Director | 5 | $0 | $0 | 2026-06-17 |
| Loy Spike | Director | 4 | $0 | $0 | 2026-06-17 |
| Moukheibir Catherine | Director | 8 | $0 | $1.15M | 2026-06-17 |
| BVF Partners OS Ltd. | Director | 1 | $0 | $0 | 2026-06-17 |
| LAMPERT MARK N | Director, 10% Owner | 3 | $0 | $62.96M | 2026-03-31 |
| Cormorant Global Healthcare Master Fund, LP | Other | 5 | $0 | $46.87M | 2025-09-30 |
| Sturge Simon | Director | 8 | $0 | $9.19M | 2025-06-05 |
| BVF INC/IL | Director, 10% Owner | 1 | $0 | $0 | 2025-06-05 |
| BVF I GP LLC | Director, 10% Owner | 3 | $0 | $100.00M | 2024-10-04 |
| BIOTECHNOLOGY VALUE FUND II LP | Director, 10% Owner | 1 | $0 | $0 | 2024-06-06 |
| Cormorant Private Healthcare Fund II, LP | 10% Owner | 1 | $3.52M | $0 | 2023-10-05 |
| Cormorant Private Healthcare Fund IV LP | 10% Owner | 3 | $16.80M | $0 | 2023-10-04 |
| Chen Bihua | 10% Owner | 35 | $105.81M | $0 | 2023-06-30 |
| BVF GP HOLDINGS LLC | Director, 10% Owner | 1 | $0 | $0 | 2023-06-08 |
| Helix Holdings LLC | Other | 2 | $0 | $0 | 2022-04-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-27 | 2026-07-29 | 1,100 | $20.00 | $22.0K | 2,711,198 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-27 | 2026-07-29 | 1,100 | $20.00 | $22.0K | 2,711,198 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-22 | 2026-07-23 | 2,448 | $20.00 | $49.0K | 2,712,298 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-21 | 2026-07-23 | 50,000 | $20.02 | $1.00M | 2,714,746 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-20 | 2026-07-21 | 43,700 | $20.09 | $877.9K | 2,764,746 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-07-15 | 2026-07-20 | 16,105 | $20.01 | $322.3K | 2,808,446 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2026-07-10 | 2026-07-13 | 68,289 | $20.02 | $1.37M | 2,774,893 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2026-07-09 | 2026-07-13 | 33,936 | $20.01 | $679.1K | 2,843,182 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2026-07-01 | 2026-07-02 | 47,775 | $20.03 | $956.9K | 2,877,118 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-06-22 | 2026-06-23 | 39,120 | $22.04 | $862.2K | 1,115,435 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-06-18 | 2026-06-18 | 2,794 | $19.60 | $54.8K | 1,154,555 | SEC↗ |
| Xavier Ramnik | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 22,195 | — | $0 | 22,195 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 22,195 | — | $0 | 22,195 | SEC↗ |
| Loy Spike | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 22,195 | — | $0 | 22,195 | SEC↗ |
| Moukheibir Catherine | Director | A Award deriv | 2026-06-17 | 2026-06-18 | 22,195 | — | $0 | 22,195 | SEC↗ |
| BVF Partners OS Ltd. | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 22,195 | — | $0 | 22,195 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-06-17 | 2026-06-17 | 50,000 | $19.43 | $971.5K | 2,824,551 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-06-17 | 2026-06-18 | 15,082 | $19.68 | $296.8K | 1,157,349 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-06-16 | 2026-06-17 | 50,000 | $18.70 | $935.0K | 2,874,551 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2026-06-15 | 2026-06-17 | 50,000 | $18.89 | $944.5K | 2,924,551 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-05-11 | 2026-05-13 | 13,653 | $20.02 | $273.3K | 1,172,431 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-04-14 | 2026-04-16 | 2,426 | $19.56 | $47.5K | 1,186,084 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2026-04-13 | 2026-04-14 | 51,873 | $18.23 | $945.6K | 2,924,893 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-04-10 | 2026-04-10 | 1,925 | $19.51 | $37.6K | 1,188,510 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2026-04-10 | 2026-04-14 | 98,127 | $18.41 | $1.81M | 2,976,766 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2026-04-09 | 2026-04-10 | 85,870 | $18.94 | $1.63M | 1,190,435 | SEC↗ |
| LAMPERT MARK N | Director, 10% Owner | S Sale | 2026-03-31 | 2026-04-02 | 248,530 | $16.79 | $4.17M | 1,039,238 | SEC↗ |
| LAMPERT MARK N | Director, 10% Owner | S Sale | 2026-03-31 | 2026-04-02 | 1,569,116 | $16.79 | $26.35M | 6,599,722 | SEC↗ |
| LAMPERT MARK N | Director, 10% Owner | S Sale | 2026-03-31 | 2026-04-02 | 1,932,354 | $16.79 | $32.44M | 8,302,735 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | A Award deriv | 2026-01-07 | 2026-01-09 | 520,342 | — | $0 | 520,342 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | A Award deriv | 2026-01-07 | 2026-01-09 | 520,342 | — | $0 | 520,342 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | A Award | 2026-01-07 | 2026-01-09 | 354,296 | — | $0 | 1,276,305 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion deriv | 2025-12-19 | 2025-12-22 | 5,836 | — | $0 | 0 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2025-12-19 | 2025-12-22 | 1,052 | — | $0 | 0 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion deriv | 2025-12-19 | 2025-12-22 | 8,754 | — | $0 | 0 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion | 2025-12-19 | 2025-12-22 | 196,316 | — | $0 | 3,074,893 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | D To issuer | 2025-12-19 | 2025-12-22 | 196,316 | — | $0 | 0 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2025-12-19 | 2025-12-22 | 35,389 | — | $0 | 35,389 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2025-12-19 | 2025-12-22 | 35,389 | — | $0 | 0 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | D To issuer | 2025-12-19 | 2025-12-22 | 294,473 | — | $0 | 0 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion | 2025-12-19 | 2025-12-22 | 294,473 | — | $0 | 922,009 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2025-12-09 | 2025-12-10 | 72,908 | $14.43 | $1.05M | 0 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2025-12-09 | 2025-12-10 | 70,000 | $14.49 | $1.01M | 2,878,577 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2025-12-08 | 2025-12-10 | 130,000 | $15.08 | $1.96M | 72,908 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2025-12-08 | 2025-12-10 | 130,000 | $15.08 | $1.96M | 2,948,577 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | P Buy | 2025-10-08 | 2025-10-09 | 10,870 | $9.09 | $98.8K | 627,536 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | S Sale | 2025-09-30 | 2025-10-01 | 5,827 | $6.96 | $40.6K | 1,994,173 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | S Sale | 2025-09-29 | 2025-10-01 | 2,800,000 | $6.61 | $18.51M | 2,000,000 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | S Sale | 2025-09-29 | 2025-10-01 | 3,390,943 | $7.58 | $25.70M | 4,800,000 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | S Sale | 2025-09-29 | 2025-10-01 | 70,748 | $9.38 | $663.6K | 8,423,403 | SEC↗ |
| Cormorant Global Healthcare Ma | Other | S Sale | 2025-09-29 | 2025-10-01 | 232,460 | $8.40 | $1.95M | 8,190,943 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2025-09-02 | 2025-09-04 | 48,978 | — | $0 | 202,908 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2025-09-02 | 2025-09-04 | 48,978 | — | $0 | 35,389 | SEC↗ |
| Moukheibir Catherine | Director | M Exercise deriv | 2025-07-03 | 2025-07-07 | 23,500 | — | $0 | 21,500 | SEC↗ |
| Moukheibir Catherine | Director | M Exercise | 2025-07-03 | 2025-07-07 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Moukheibir Catherine | Director | S Sale | 2025-07-03 | 2025-07-07 | 23,500 | $48.79 | $1.15M | 0 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| Moukheibir Catherine | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| Xavier Ramnik | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| Loy Spike | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| Sturge Simon | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| BVF INC/IL | Director, 10% Owner | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | A Award deriv | 2025-02-27 | 2025-03-03 | 139,273 | — | $0 | 139,273 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | A Award | 2025-02-27 | 2025-03-03 | 95,763 | — | $0 | 616,666 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | A Award | 2025-02-27 | 2025-03-03 | 95,763 | — | $0 | 3,078,577 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2025-01-20 | 2025-09-04 | 1,456 | — | $0 | 1,052 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2025-01-20 | 2025-01-22 | 3,328 | — | $0 | 2,508 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2025-01-20 | 2025-01-22 | 111,949 | — | $0 | 153,930 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2025-01-20 | 2025-01-22 | 111,949 | — | $0 | 84,367 | SEC↗ |
| Sturge Simon | Director | S Sale | 2024-10-04 | 2024-10-08 | 171,000 | $53.72 | $9.19M | 171,980 | SEC↗ |
| BVF I GP LLC | Director, 10% Owner | S Sale | 2024-10-04 | 2024-10-08 | 1,030,589 | $50.00 | $51.53M | 10,235,089 | SEC↗ |
| BVF I GP LLC | Director, 10% Owner | S Sale | 2024-10-04 | 2024-10-08 | 132,549 | $50.00 | $6.63M | 1,287,768 | SEC↗ |
| BVF I GP LLC | Director, 10% Owner | S Sale | 2024-10-04 | 2024-10-08 | 836,862 | $50.00 | $41.84M | 8,168,838 | SEC↗ |
| Loy Spike | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Sturge Simon | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Xavier Ramnik | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Moukheibir Catherine | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 7,688 | — | $0 | 7,688 | SEC↗ |
| BIOTECHNOLOGY VALUE FUND II LP | Director, 10% Owner | A Award deriv | 2024-06-06 | 2024-06-10 | 7,688 | — | $0 | 7,688 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-29 | 2024-02-29 | 4,740 | $55.89 | $264.9K | 2,982,814 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-28 | 2024-02-29 | 31,910 | $55.00 | $1.76M | 2,925,573 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-28 | 2024-02-29 | 28,090 | $55.00 | $1.54M | 41,981 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-28 | 2024-02-29 | 56,065 | $55.00 | $3.08M | 2,987,554 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-27 | 2024-02-29 | 29,431 | $55.00 | $1.62M | 70,071 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-27 | 2024-02-29 | 29,491 | $55.00 | $1.62M | 2,957,483 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-27 | 2024-02-29 | 62,810 | $55.00 | $3.45M | 3,043,619 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-21 | 2024-02-22 | 569 | $55.30 | $31.5K | 99,502 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-21 | 2024-02-22 | 509 | $55.31 | $28.2K | 2,986,974 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-21 | 2024-02-23 | 1,125 | $55.27 | $62.2K | 3,106,429 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-20 | 2024-02-20 | 20,000 | $57.44 | $1.15M | 3,107,554 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-20 | 2024-02-22 | 10,000 | $57.43 | $574.3K | 100,071 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-20 | 2024-02-22 | 10,000 | $57.45 | $574.5K | 2,987,483 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-16 | 2024-02-16 | 10,000 | $60.15 | $601.5K | 110,071 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-16 | 2024-02-16 | 10,000 | $60.15 | $601.5K | 2,997,483 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-16 | 2024-02-20 | 20,000 | $60.15 | $1.20M | 3,127,554 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-15 | 2024-02-16 | 10,000 | $60.16 | $601.6K | 120,071 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-15 | 2024-02-16 | 10,000 | $60.17 | $601.7K | 3,007,483 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | S Sale | 2024-02-15 | 2024-02-20 | 20,000 | $60.18 | $1.20M | 3,147,554 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-14 | 2024-02-16 | 10,000 | $62.42 | $624.2K | 3,017,483 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | S Sale | 2024-02-14 | 2024-02-16 | 10,000 | $62.43 | $624.3K | 130,071 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2023-12-20 | 2023-12-21 | 5,264 | $58.34 | $307.1K | 520,903 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | S Sale | 2023-12-19 | 2023-12-21 | 94,736 | $59.22 | $5.61M | 526,167 | SEC↗ |
| Cormorant Private Healthcare F | 10% Owner | P Buy | 2023-10-05 | 2023-10-10 | 58,839 | $59.90 | $3.52M | 8,494,151 | SEC↗ |
| Cormorant Private Healthcare F | 10% Owner | P Buy | 2023-10-04 | 2023-10-04 | 67,814 | $57.32 | $3.89M | 8,435,312 | SEC↗ |
| Cormorant Private Healthcare F | 10% Owner | P Buy | 2023-10-03 | 2023-10-04 | 150,487 | $57.25 | $8.62M | 8,367,498 | SEC↗ |
| Cormorant Private Healthcare F | 10% Owner | P Buy | 2023-10-02 | 2023-10-04 | 74,911 | $57.37 | $4.30M | 8,217,011 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2023-10-01 | 2023-10-03 | 1,248 | — | $0 | 5,836 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2023-10-01 | 2023-10-03 | 75,136 | — | $0 | 0 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion deriv | 2023-10-01 | 2023-10-03 | 4,164 | — | $0 | 5,836 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion deriv | 2023-10-01 | 2023-10-03 | 90,000 | — | $0 | 0 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion deriv | 2023-10-01 | 2023-10-03 | 1,872 | — | $0 | 8,754 | SEC↗ |
| Sturge Simon | Director | C Conversion deriv | 2023-10-01 | 2023-10-03 | 10,196 | — | $0 | 0 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2023-10-01 | 2023-10-03 | 2,527,477 | — | $0 | 3,027,483 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2023-10-01 | 2023-10-03 | 41,981 | — | $0 | 140,071 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2023-10-01 | 2023-10-03 | 41,981 | — | $0 | 196,316 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2023-10-01 | 2023-10-03 | 2,527,477 | — | $0 | 0 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | D To issuer | 2023-10-01 | 2023-10-03 | 140,071 | — | $0 | 217,374 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion | 2023-10-01 | 2023-10-03 | 3,027,483 | — | $0 | 3,027,483 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | D To issuer | 2023-10-01 | 2023-10-03 | 3,027,483 | — | $0 | 0 | SEC↗ |
| Santos da Silva Jorge | Chief Executive Officer | C Conversion | 2023-10-01 | 2023-10-03 | 140,071 | — | $0 | 3,167,554 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion | 2023-10-01 | 2023-10-03 | 62,972 | — | $0 | 620,903 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | D To issuer | 2023-10-01 | 2023-10-03 | 62,972 | — | $0 | 294,473 | SEC↗ |
| Sturge Simon | Director | C Conversion | 2023-10-01 | 2023-10-03 | 342,980 | — | $0 | 342,980 | SEC↗ |
| Sturge Simon | Director | D To issuer | 2023-10-01 | 2023-10-03 | 342,980 | — | $0 | 0 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-30 | 2023-07-05 | 800,000 | $50.00 | $40.00M | 4,927,100 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 21,823 | $53.98 | $1.18M | 4,102,304 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 4,725 | $52.81 | $249.5K | 4,080,481 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 8,697 | $52.01 | $452.3K | 4,075,756 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 17,662 | $50.77 | $896.7K | 4,067,059 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 59,787 | $49.82 | $2.98M | 4,049,397 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 37,783 | $48.93 | $1.85M | 3,989,610 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 10,946 | $44.93 | $491.8K | 3,951,827 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 31,558 | $44.23 | $1.40M | 3,940,881 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 66,087 | $43.30 | $2.86M | 3,909,323 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 61,042 | $42.12 | $2.57M | 3,843,236 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 50,642 | $41.03 | $2.08M | 3,782,194 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 38,623 | $39.87 | $1.54M | 3,731,552 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 10,593 | $39.17 | $414.9K | 3,692,929 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 3,755 | $38.18 | $143.4K | 3,682,336 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 1,481 | $36.91 | $54.7K | 3,678,581 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 85 | $72.46 | $6.2K | 4,127,100 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 15 | $70.62 | $1.1K | 4,127,015 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 16 | $65.32 | $1.0K | 4,127,000 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 95 | $64.44 | $6.1K | 4,126,984 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 139 | $63.85 | $8.9K | 4,126,889 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 136 | $62.20 | $8.5K | 4,126,750 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 417 | $60.21 | $25.1K | 4,126,614 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 1,302 | $58.98 | $76.8K | 4,126,197 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 295 | $57.63 | $17.0K | 4,124,895 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 1,894 | $56.89 | $107.7K | 4,124,600 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 1,453 | $55.83 | $81.1K | 4,122,706 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-06-26 | 2023-06-28 | 18,949 | $54.92 | $1.04M | 4,121,253 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| Moukheibir Catherine | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| Loy Spike | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| Xavier Ramnik | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| Sturge Simon | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| BVF GP HOLDINGS LLC | Director, 10% Owner | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2023-04-05 | 2023-04-07 | 14,864 | — | $0 | 75,136 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion deriv | 2023-04-05 | 2023-04-07 | 2,916 | — | $0 | 7,084 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion deriv | 2023-04-05 | 2023-04-07 | 4,374 | — | $0 | 10,626 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion deriv | 2023-04-05 | 2023-04-07 | 12,212 | — | $0 | 0 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2023-04-05 | 2023-04-07 | 500,006 | — | $0 | 2,527,477 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2023-04-05 | 2023-04-07 | 500,006 | — | $0 | 500,006 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | C Conversion | 2023-04-05 | 2023-04-07 | 98,090 | — | $0 | 98,090 | SEC↗ |
| Reich Kristian | Chief Scientific Officer | D To issuer | 2023-04-05 | 2023-04-07 | 98,090 | — | $0 | 238,297 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion | 2023-04-05 | 2023-04-07 | 147,135 | — | $0 | 557,931 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | D To issuer | 2023-04-05 | 2023-04-07 | 147,135 | — | $0 | 357,445 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | C Conversion | 2023-04-05 | 2023-04-07 | 410,796 | — | $0 | 410,796 | SEC↗ |
| Bodenstedt Matthias | Chief Financial Officer | D To issuer | 2023-04-05 | 2023-04-07 | 410,796 | — | $0 | 0 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-03-21 | 2023-03-22 | 238,511 | $21.70 | $5.18M | 3,677,100 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-03-20 | 2023-03-22 | 446,881 | $19.36 | $8.65M | 3,296,881 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-03-20 | 2023-03-22 | 63,700 | $20.42 | $1.30M | 3,360,581 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2023-03-20 | 2023-03-22 | 78,008 | $21.08 | $1.64M | 3,438,589 | SEC↗ |
| Phillips Andrew John | Director | A Award deriv | 2022-04-06 | 2022-05-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Moukheibir Catherine | Director | A Award deriv | 2022-04-06 | 2022-05-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Xavier Ramnik | Director | A Award deriv | 2022-04-06 | 2022-05-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Sturge Simon | Director | A Award deriv | 2022-04-06 | 2022-05-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Chen Bihua | 10% Owner | C Conversion deriv | 2022-04-05 | 2022-04-07 | 2,785,000 | — | $0 | 0 | SEC↗ |
| Helix Holdings LLC | Other | C Conversion deriv | 2022-04-05 | 2022-04-07 | 2,785,000 | — | $0 | 0 | SEC↗ |
| Chen Bihua | 10% Owner | C Conversion | 2022-04-05 | 2022-04-07 | 2,785,000 | — | $0 | 3,215,000 | SEC↗ |
| Chen Bihua | 10% Owner | P Buy | 2022-04-05 | 2022-04-07 | 2,850,000 | $10.00 | $28.50M | 2,850,000 | SEC↗ |
| Helix Holdings LLC | Other | C Conversion | 2022-04-05 | 2022-04-07 | 2,785,000 | — | $0 | 3,215,000 | SEC↗ |